›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:SureSeq CLL + CNV V3 NGS Panel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Sysmex CorpType:
Laboratory Developed Test
Related tests:
SureSeq™ CLL + CNV V3 Panel allows you to target 16 key disease-associated genes and 5 chromosomal regions implicated in CLL progression, including enhanced TP53 variant detection.
Cancer:
Chronic Lymphocytic Leukemia
Gene:
ATM (ATM serine/threonine kinase), BCL2 (B-cell CLL/lymphoma 2), BIRC3 (Baculoviral IAP repeat containing 3), BRAF (B-raf proto-oncogene), BTK (Bruton Tyrosine Kinase), CXCR4 (Chemokine (C-X-C motif) receptor 4)
See More ...
ATM (ATM serine/threonine kinase), BCL2 (B-cell CLL/lymphoma 2), BIRC3 (Baculoviral IAP repeat containing 3), BRAF (B-raf proto-oncogene), BTK (Bruton Tyrosine Kinase), CXCR4 (Chemokine (C-X-C motif) receptor 4), KRAS (KRAS proto-oncogene GTPase), MYB (MYB Proto-Oncogene, Transcription Factor), MYD88 (MYD88 Innate Immune Signal Transduction Adaptor), NOTCH1 (Notch 1), NRAS (Neuroblastoma RAS viral oncogene homolog), PLCG2 (Phospholipase C Gamma 2), SAMHD1 (SAM And HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase 1), SF3B1 (Splicing Factor 3b Subunit 1), TP53 (Tumor protein P53), XPO1 (Exportin 1)
Method:
Next-Generation-Sequencing
